Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
1 hedge funds and large institutions have $0 invested in Genesis Healthcare, Inc. in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 7 closing their positions.
88% less funds holding
Funds holding: 8 → 1 (-7)
100% less capital invested
Capital invested by funds: $1.08M → $0 (-$1.08M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 7
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$631K |
| 2 |
IC
Iconiq Capital
San Francisco,
California
|
-$395K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
-$49K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
GEN Hedge Fund Activity: Q2 2021 in Review
1 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q2 2021, worth a combined $0 — down 100% from $1.08M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of GEN and 0 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Acadian Asset Management, exiting entirely with an estimated $631K sold.
- 1 institutional investor held Genesis Healthcare, Inc. (GEN) as of Q2 2021, down from 8 in Q1 2021.
- Funds reported $0 of Genesis Healthcare, Inc. stock for Q2 2021, down 100% quarter-over-quarter.
- 0 funds opened new Genesis Healthcare, Inc. positions in Q2 2021 and 7 closed out, a net change of -7 holders.
- The largest Genesis Healthcare, Inc. seller in Q2 2021 was Acadian Asset Management, an estimated $631K sold.
Based on aggregated 13F filings for Q2 2021.